FDFs (Finished Dosage Forms)
Indoco operates on CRAMS model (Contract Research And Manufacturing Services) and currently caters to Generic Companies in Europe, USA, Australia, New Zealand and South Africa.
While we have established our credentials by offering contract manufacturing services, Indoco has now risen in the value chain by offering dossier development services and out-licensing of our own dossiers.
Creams & Ointments
Having consolidated its presence in Regulated markets of Europe and with an impressive entry in US markets, Indoco has also strengthened its presence in the Emerging markets for over a decade.Regulated Markets Product List
Currently, we export our products to countries like Algeria, Benin, Bolivia, Botswana, Burkina Faso, Cameroon, Congo, Ethiopia, Gabon, Guatemala, Haiti, Honduras, Jordan, Iraq, Ivory Coast, Kenya, Malaysia, Mali, Mauritius, Moldova, Morocco, Myanmar, Mozambique, Namibia, Niger, Peru, Senegal, Philippines, Sri Lanka, Sudan, Swaziland, Tanzania, Thailand, Trinidad & Tobago, UAE, Ukraine, Uganda, Yemen, Zambia and Zimbabwe. Thus, Indoco’s global stride in Emerging markets extends across 41 countries in four continents, viz., South East Asia, Africa, Latin America, Caribbean and CIS. We have 450 active product registrations and another 300 pending registrations.
We are consistently delivering high quality products at affordable prices and are constantly upgrading our offerings into these markets.
Our marketing efforts for branded generics are highly focused with country specific promotional inputs. The trained and motivated Sales force is responsible to generate prescriptions and build customer loyalty.
In addition, introduction of new products in existing markets and entry in new territories will spur the growth in Emerging markets.
Products in new therapeutic segments are being targeted at existing, as well as new markets to further strengthen Indoco’s presence in the Emerging markets.Emerging Markets Product List
Indoco offers its state-of-the-art facilities for manufacturing of various Finished Dosage Forms for exports to Regulated markets and Rest of the World.
The manufacturing facilities hold good capacities and are managed by efficient and skilled professionals. We ensure consistent quality and timely delivery.
Dosages manufactured and their annual capacities:
Tablets / Capsules : 8.8 Billion
Liquid Orals : 60 Million Bottles
Creams and Ointments : 45 Million Tubes
Toothpastes : 25 Million Tubes
Sterile Ophthalmic Solutions : 60 Million (Vials and Ampoules)
Active Pharmaceutical Ingredients : 50 m3 Capacity
Indoco has world class facilities and capabilities in Formulation Development and Compilation of ANDA/Dossiers in CTD.
The development in formulations includes:
Tablets (Uncoated/ Coated/ SR/ XR)
Capsules (Hard Gelatin)
Creams and Ointments
Expertise in formulation development and an in-house regulatory division with a competent team makes us an ideal partner for development of the product, presenting a Dossier in CTD format and rendering all the support required to get the product registered, followed by an uninterrupted supply of the products thereafter.Dossier Markets Product List
Analytical Method Development department has qualified & well equipped chemists who can undertake work as per ICH guidelines.
Indoco is working with few US/ European clients for development of analytical methods for their products. A few contracts have been completed already by delivering/ compiling data and services to the satisfaction of the customers.
Indoco out-licenses its products for sale and distribution in the Regulated and Emerging markets.